Jesse A. Salen

Specialty / Focus. Jesse A. Salen is an intellectual property litigator whose practice spans patent litigation, prosecution, and licensing, with stated emphasis on healthcare IT, medical software, medical devices, optics/nanotechnology, computer devices, and data storage (Nat'l Law Review bio; Sheppard Mullin bio). His docket is broader in practice, however, and includes Hatch-Waxman/ANDA cases, design patents, and wireless/SEP litigation. His tracked matter — Teladoc Health Inc. v. Data Health Partners Inc. — involves telehealth patient-goal tracking and diabetes-management platform patents (U.S. Patent Nos. 10,061,812; 11,144,554; 11,151,142; 11,809,431), squarely in his healthcare-software wheelhouse.

Side preference. The tracked case is plaintiff/petitioner-side (Salen is lead counsel for Teladoc Health in the related PTAB IPRs against Data Health Partners, e.g., IPR2024-00616/617/618 and pending IPR2026-00391). Historically he works both sides: he has defended operating companies (Teladoc, Snap, HTC, Ricoh, TCL, generic drugmaker Alembic) and has also led enforcement work for plaintiffs (Blueprint Studios, Prestige Flag, SkimDevil, Lamps Plus). His profile is that of a mixed practice, not an NPE/PAE specialist.

Firm context. Partner in the Intellectual Property Practice Group at Sheppard, Mullin, Richter & Hampton LLP (San Diego/Del Mar office), where he joined as an associate after graduating law school in 2013; no prior law firm is documented. Before law, he spent 16 years in industry, including as CTO of telemedicine startup ONRAD, Inc. and at GE Healthcare, Hitachi Data Systems, Memorial Sloan-Kettering, and Micrion.

Notable matters / outcomes. His strongest verified results: trial-team role in the TCL v. Ericsson FRAND dispute (C.D. Cal.) that produced favorable SEP royalty rates for TCL; a complete non-infringement verdict for Alembic Pharmaceuticals in the Trintellix ANDA case, Lundbeck v. Apotex (D. Del.); Alice-based dismissals with prejudice for Teladoc (American Well v. Teladoc, D. Mass.) and Snap (Sanderling v. Snap, C.D. Cal.), the latter affirmed by the Federal Circuit (No. 21-2173). In the tracked dispute, his client Teladoc lost a § 101 motion-to-dismiss fight in the parallel D. Del. case (Data Health Partners v. Teladoc, 1:23-cv-00160-JCG, May 2024) and had IPR2024-00618 denied institution, with a fresh petition pending in IPR2026-00391.

PTAB / IPR experience. Substantial. He has appeared as lead or counsel in IPRs on both sides — patent owner (Gridco v. Varentec, defeating institution; Bio-Rad v. Caltech, IPR2024-01177) and petitioner (KSP v. Guala Pack; eight TCL v. Ericsson IPRs; the Teladoc v. Data Health Partners petitions).

Bar / education. California bar (2013); USPTO; Federal Circuit; Ninth Circuit. J.D., University of San Diego (magna cum laude, Order of the Coif); MBA, UC Irvine; B.A. in Physics, Boston University (sources: Martindale, Sheppard Mullin bio, LawTally).